The International Cannabis and Cannabinoids Institute is proud to present its first online webinar with Dr. Ethan Russo, Making Cannabis Safer and Better. Our webinars are designed to share our expertise on cannabis, and provide insight to enthusiasts, patients and medical professionals.
During the seminar presented by Dr. Russo, you will learn the following:
- Details on cannabis preparations, components, and pitfalls in cultivation
- Best practices and selective breeding for cannabis composition
- Applications of cannabis for treating a variety of conditions, including information on dosage and methods of administration
Cannabis laws are loosening in most parts of the world. Many hurdles remain pertaining to the quality, consistency, safety and efficacy of its production and processing. These include proper cultivation techniques, avoiding pesticide and heavy metal contaminants, and selecting cannabis varieties with the most efficacious components for medical use. This webinar will present detailed information on the cultivation and composition of cannabis, and will address how specific cannabis preparations are produced and used to treat a range of medical conditions.
The length of the webinar is two hours. It will start with a one and a half hour presentation by Dr. Russo, followed by 30 minutes for questions and open discussion.
The webinar takes place on the 9th of April, 2019 at:
- 10:00 AM EST
- 11:00 AM EDT
- 17:00 CEST
You can register for the webinar at the following link for 30 euro: ICCI Webinars
You can follow event updates on Facebook
If you would like more information about the webinar, please contact: firstname.lastname@example.org.
Biography: Ethan Russo, MD
Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Director of Research and Development for the International Cannabis and Cannabinoids Institute. Previously, he was Medical Director of PHYTECS, 2015-2017, and from 2003-2014, he was Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®. He graduated from the University of Pennsylvania, and the University of Massachusetts Medical School, before residencies in Pediatrics in Phoenix, and in Child/Adult Neurology at the University of Washington, Seattle. He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. Ethan is a former president of the International Cannabinoid Research Society and former Chairman of the International Association for Cannabinoid Medicines. He is author/editor of seven books on cannabis and medicinal herbs, and has also published numerous book chapters, and over fifty articles in neurology, pain management, cannabis, and ethnobotany.